PharmEasy secures ₹1,300 crore from Ranjan Pai and an oversubscribed ₹3,500 crore rights issue. Ranjan Pai, Chairman of Manipal Education and Medical Group, has made a noteworthy financial commitment by…
Key Notes About PharmEasy According to two sources briefed on the situation, the parent company of PharmEasy, API Holdings, increased the size of its rights issuance from Rs 2,000-2,400 crore…
PharmEasy Achieves First EBITDA Profit of ₹14 Crore, Reopens Funding Discussions! People familiar with PharmEasy 's most recent financials claim that the online pharmacy had a positive ebitda in April…
PharmEasy Founders Commit to Retaining Thyrocare and Reducing Cash Burn PharmEasy 's founders informed the Board earlier this month that they will not sell Thyrocare, the company's diagnostic division. The…
API Holdings Aims for Profitability Despite Widening Losses in FY22 API Holdings, which owns PharmEasy and is planning an IPO, intends to become profitable on an Ebitda basis in the…
Pharmeasy Rights Issue details Issue Size: 750 Crores Rights Entitlement Ratio: 1 CCPS for every 82 Shares held Record Date: September 9, 2022 Issue Price: ₹100 /- per CCPS (Premium…
PharmEasy (API Holdings Ltd) Proposed issuance Notice under the shareholders agreement for rights issue CCPS 1. Withdrawal of DRHP the Company is desirous of undertaking a capital raise. Due to…
PharmEasy Pre-IPO Shares: Key Insights The pharmaceutical sector has always been as chaotic as we can imagine. Though we were all pleased with the wholesale and retail market structures provided…
PharmEasy in Talks to Raise $200M at Lower Valuation PharmEasy is in talks with investors to raise $200 million, but at a value that might be 15% or even 25%…